• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Isoconazole Nitrate

European Union chaplet of stars
General Notices

(Ph. Eur. monograph 1017)

bp2012_v1_07_medicinal_and_pharmaceutical_substances_9 isoconazolenitrate_1_2012_70_cs.png


C18H14Cl4N2O,HNO3    479.1    24168-96-5

Action and use

Antifungal.

Preparation

Isoconazole Pessaries

Ph Eur

DEFINITION

1-[(2RS)-2-[(2,6-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate.

Content

99.0 per cent to 101.0 per cent (dried substance).

CHARACTERS
Appearance

White or almost white powder.

Solubility

Very slightly soluble in water, soluble in methanol, slightly soluble in ethanol (96 per cent).

IDENTIFICATION

First identification  A, B.

Second identification  A, C, D.

A. Melting point (2.2.14): 178 °C to 182 °C.

B. Infrared absorption spectrophotometry (2.2.24).

Preparation  Discs.

Comparison  isoconazole nitrate CRS.

C. Thin-layer chromatography (2.2.27).

Test solution  Dissolve 30 mg of the substance to be examined in methanol R and dilute to 5 mL with the same solvent.

Reference solution (a)  Dissolve 30 mg of isoconazole nitrate CRS in methanol R and dilute to 5 mL with the same solvent.

Reference solution (b)  Dissolve 30 mg of isoconazole nitrate CRS and 30 mg of econazole nitrate CRS in methanol R, then dilute to 5 mL with the same solvent.

Plate  TLC octadecylsilyl silica gel plate R.

Mobile phase  ammonium acetate solution R, dioxan R, methanol R (20:40:40 V/V/V).

Application  5 µL.

Development  Over a path of 15 cm.

Drying  In a current of warm air for 15 min.

Detection  Expose to iodine vapour until the spots appear and examine in daylight.

System suitability  Reference solution (b):

  • — the chromatogram shows 2 clearly separated spots.

Results  The principal spot in the chromatogram obtained with the test solution is similar in position, colour and size to the principal spot in the chromatogram obtained with reference solution (a).

D. It gives the reaction of nitrates (2.3.1).

TESTS
Solution S

Dissolve 0.20 g in methanol R and dilute to 20.0 mL with the same solvent.

Appearance of solution

Solution S is clear (2.2.1) and not more intensely coloured than reference solution Y7 (2.2.2, Method II).

Optical rotation (2.2.7)

- 0.10° to + 0.10°, determined on solution S.

Related substances

Liquid chromatography (2.2.29).

Test solution  Dissolve 0.100 g of the substance to be examined in the mobile phase and dilute to 10.0 mL with the mobile phase.

Reference solution (a)  Dissolve 2.5 mg of isoconazole nitrate CRS and 2.5 mg of econazole nitrate CRS in the mobile phase, then dilute to 100.0 mL with the mobile phase.

Reference solution (b)  Dilute 1.0 mL of the test solution to 100.0 mL with the mobile phase. Dilute 5.0 mL of this solution to 20.0 mL with the mobile phase.

Column:
  • sizel = 0.1 m, Ø = 4.6 mm;

Mobile phase  Dissolve 6.0 g of ammonium acetate R in a mixture of 300 mL of acetonitrile R, 320 mL of methanol R and 380 mL of water R.

Flow rate  2 mL/min.

Detection  Spectrophotometer at 235 nm.

Equilibration  With the mobile phase for about 30 min.

Injection  10 µL.

Run time  1.5 times the retention time of isoconazole.

Retention time  Econazole = about 10 min; isoconazole = about 14 min.

System suitability  Reference solution (a):

  • resolution: minimum 5.0 between the peaks due to econazole and isoconazole; if necessary, adjust the composition of the mobile phase.
Limits:
  • impurities A, B, C: for each impurity, not more than the area of the principal peak in the chromatogram obtained with reference solution (b) (0.25 per cent);
  • total: not more than twice the area of the principal peak in the chromatogram obtained with reference solution (b) (0.5 per cent);
  • disregard limit: 0.2 times the area of the principal peak in the chromatogram obtained with reference solution (b) (0.05 per cent); disregard the peak due to the nitrate ion.
Loss on drying (2.2.32)

Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105 °C for 2 h.

Sulfated ash (2.4.14)

Maximum 0.1 per cent, determined on 1.0 g.

ASSAY

Dissolve 0.350 g in 75 mL of a mixture of 1 volume of anhydrous acetic acid R and 7 volumes of methyl ethyl ketone R. Titrate with 0.1 M perchloric acid, determining the end-point potentiometrically (2.2.20).

1 mL of 0.1 M perchloric acid is equivalent to 47.91 mg of C18H15Cl4N3O4.

STORAGE

Protected from light.

IMPURITIES

Specified impurities  A, B, C.

bp2012_v1_07_medicinal_and_pharmaceutical_substances_9 isoconazolenitrate_2_2012_70_cs.png


A. (1RS)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol,

bp2012_v1_07_medicinal_and_pharmaceutical_substances_9 isoconazolenitrate_3_2012_70_cs.png


B. (2RS)-2-[(2,6-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine,

bp2012_v1_07_medicinal_and_pharmaceutical_substances_9 isoconazolenitrate_4_2012_70_cs.png


C. 1-[(2RS)-2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole.

Ph Eur